MENU
CCCC
AS OF
Feb 4, 04:59 PM (EDT)
Price
$1.89
Change
-$0.12 (-5.97%)
Capitalization
195.28M
15 days until earnings call
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
CCCC
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

C4 Therapeutics (CCCC) Ownership - Who owns C4 Therapeutics?

C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients’ lives... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
N/A
Address
490 Arsenal Way
Phone
+1 617 231-0700
Employees
145
Web
https://www.c4therapeutics.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
195.28M
P/E Ratio
N/A
Total Cash
191.88M
Projected Growth
N/A
Total Debt
61.46M
Revenue
30.11M
Risk (Beta)
4.72
Dividend Yield
N/A
Total Cash/Share
1.98
Total Debt/Equity
N/A
Revenue/Share
0.42 USD as % of share price

Fundamentals

CCCC
Capitalization
195M
P/E Ratio
N/A
Risk (Beta)
4.72
Dividend Yield
N/A
Total Cash
192M
Total Cash/Share
1.98
Total Debt
61.5M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.42%
Revenue
30.1M
ROE
N/A
Book Value
154M
P/B Ratio
1.26
Cash Flow
N/A
Earnings
-1.67
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
7K
Current Ratio
5.76
Current Revenue Per Employee
102090.91
Dividends Per Share - Security
N/A
EBITDA
-105.05M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-37.12
Shares Held By Institutions
131M
Shares Outstanding - Current
96.9M
Total Liabilities
111M
Total Volume MTD
N/A
Value
1
Gain YTD
5.236
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
CCCC
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. CCCC showed earnings on November 06, 2025. You can read more about the earnings report here.
View AI-Driven Trading for CCCC
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
490 Arsenal Way
Phone
+1 617 231-0700
Employees
145
Web
https://www.c4therapeutics.com